Author

David Shelton

Pfizer (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:development & morphogenesis· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Alexandra CiuciuiD· 1 shared Ashkan SedighiD· 1 shared Ibtesam RajpariD· 1 shared John A. Collins· 1 shared Kathryn E. GroppiD· 1 shared Nicholas J. RuggieroiD· 1 shared Patrice C. Bélanger· 1 shared Ryan E. TomlinsoniD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

Alexandra CiuciuORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

The Effect of Celecoxib and muMab911 on Strain Adaptive Bone Remodeling and Fracture Repair in Female Mice: Implications for Rapidly Progressive Osteoarthritis

Nicholas J. Ruggiero, Alexandra Ciuciu, Ashkan Sedigh, Ibtesam Rajpar, David Shelton, Patrice C. Bélanger, Kathryn E. Gropp, John A. Collins, Theresa A. Freeman, Ryan E. Tomlinson

This study examines the effects of celecoxib and muMab911 on bone remodeling and fracture repair in mice, finding they suppress NGF expression and load-induced bone formation, potentially contributing to rapid osteoarthritis progression.

Bone · May 23, 2025Peer-reviewedBioengineering